Osimertinib – effective treatment of NSCLC with activating...

Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors

Skrzypski, Marcin, Szymanowska-Narloch, Amelia, Dziadziuszko, Rafał
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Year:
2017
Language:
english
Journal:
Współczesna Onkologia
DOI:
10.5114/wo.2017.70116
File:
PDF, 68 KB
english, 2017
Conversion to is in progress
Conversion to is failed